Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Resectable brain metastases.

Michael A Vogelbaum1, John H Suh

  • 1Brain Tumor Institute/ND40, Cleveland Clinic Foundation, Cleveland, OH, USA. vogelbm@neus.ccf.org

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|March 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low-Dose Brachytherapy for Choroidal Melanoma: A Preliminary Report.

Ophthalmology. Retina·2026
Same author

Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Outcomes of a third course of salvage spine stereotactic radiosurgery for spinal metastases: a single-institution case series.

Journal of neuro-oncology·2026
Same author

Local Control Outcomes of Patients With Brain Metastases From Small Cell Lung Cancer Treated With Stereotactic Radiosurgery.

American journal of clinical oncology·2026
Same author

Advances in Biology, Detection, and Treatment of Brain Metastases.

Cancer journal (Sudbury, Mass.)·2026
Same author

The impact of the molecular and genetic properties of glioblastoma on patient outcomes following stereotactic radiosurgery at recurrence.

Journal of neuro-oncology·2025
Same journal

Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Risk Prognostication After Hypomethylating Agents Combined With Venetoclax in AML: The PRISM Risk Model.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Phase I/II Study of Sonrotoclax (BGB-11417) Monotherapy in Patients With Mantle Cell Lymphoma Previously Treated With Anti-CD20 Therapy and a Bruton Tyrosine Kinase Inhibitor.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same journal

Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2026.3.2.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
See all related articles

Surgical resection of brain metastases, once palliative, now improves survival in selected patients. Advanced techniques and treatments enhance tumor control, making systemic disease status key to overall survival.

Area of Science:

  • Neurosurgery
  • Oncology
  • Radiotherapy

Background:

  • Brain metastases are the most common intracranial tumors, representing over half of all brain tumors.
  • Historically, surgical resection was viewed as palliative, but its role in improving survival is increasingly recognized.
  • Advancements in surgical techniques aim to minimize morbidity associated with tumor removal.

Purpose of the Study:

  • To review the evolving role of surgical resection in managing brain metastases.
  • To discuss newer surgical adjuncts and treatment modalities for brain metastases.
  • To highlight the impact of systemic disease control on patient survival.

Main Methods:

  • Review of current literature on surgical techniques and adjuvant therapies for brain metastases.

Related Experiment Videos

  • Analysis of the impact of image-guided surgery and stereotactic radiosurgery on tumor control.
  • Evaluation of factors influencing overall survival in patients with brain metastases.

    • Main Results:

    • Surgical resection, when applied to appropriately selected patients, can extend survival.
    • Minimally invasive surgical techniques have reduced the complications associated with tumor resection.
    • Image-guided surgery and stereotactic radiosurgery offer superior tumor control within the brain.

    Conclusions:

    • The management of brain metastases has shifted towards a more aggressive, multidisciplinary approach.
    • While radiotherapy remains important, surgical adjuncts are being explored to potentially reduce its necessity.
    • Patient survival is now significantly influenced by the control of extracranial (systemic) disease.